Uncategorized

by Helen Stillwell The results from a phase I clinical trial to test the safety and immunogenicity of a universal flu vaccine candidate reported encouraging results €“ strong titers of broad and functional antibodies persisted for over a year in healthy adults following vaccination.  Influenza viruses contain segmented RNA genomes. The viral envelope contains two types glycoproteins […]

By David Tuller, DrPH On November 10th, the National Institute of Health and Care Excellence published a draft of new clinical guidelines for ME/CFS. The draft represented a blunt rejection of the argument that the combination of “unhelpful cognitions” and deconditioning drives the illness. Under this once-hegemonic framework, indicated therapies include cognitive behavior therapy to

By David Tuller, DrPH Earlier today, I posted a blog about the decision by the Royal College of General Practice to remove from its site a training program called METRIC, which promoted the GET/CBT approach. I then sent the following letter to Carolyn Chew-Graham, a professor of general practice research at Keele University in Staffordshire

By David Tuller, DrPH In early 2019, I wrote about an awful online training course for general practitioners on recognizing and caring for patients diagnosed with what was referred to as CFS/ME. The module, called METRIC, promised to provide “GPs and other primary care practitioners with an overview of the presentation, diagnosis, assessment and ongoing

By David Tuller, DrPH Mahana set to announce FDA approval for ineffective IBS program Earlier this year, I spent a lot of time blogging about the unethical and dishonest manner in which a San Francisco start-up called Mahana Therapeutics was promoting an eight-week web-based program of cognitive behavior therapy for patients suffering from irritable bowel

By David Tuller, DrPH Earlier this week, I blogged about a story in The Observer that provided an inaccurate description of what it called chronic fatigue syndrome. For much of the piece, the writer, Eleanor Morgan, offered a sympathetic portrait of people, including herself, experiencing prolonged symptoms after an acute bout of Covid-19. A lot